LV13441B - A method for the preparation of enantiomercally pure mirtazapine - Google Patents
A method for the preparation of enantiomercally pure mirtazapine Download PDFInfo
- Publication number
- LV13441B LV13441B LVP-06-21A LV060021A LV13441B LV 13441 B LV13441 B LV 13441B LV 060021 A LV060021 A LV 060021A LV 13441 B LV13441 B LV 13441B
- Authority
- LV
- Latvia
- Prior art keywords
- acid
- combination
- solvent
- compound
- mirtazapine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03102095 | 2003-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LV13441B true LV13441B (en) | 2006-08-20 |
Family
ID=34042934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-06-21A LV13441B (en) | 2003-07-10 | 2006-02-10 | A method for the preparation of enantiomercally pure mirtazapine |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US8058436B2 (es) |
| EP (1) | EP1656365B1 (es) |
| JP (1) | JP4668184B2 (es) |
| KR (1) | KR20060056315A (es) |
| CN (1) | CN100558722C (es) |
| AR (1) | AR046494A1 (es) |
| AT (1) | ATE433965T1 (es) |
| AU (1) | AU2004255874B2 (es) |
| BR (1) | BRPI0412447A (es) |
| CA (1) | CA2531165C (es) |
| CO (1) | CO5640123A2 (es) |
| CY (1) | CY1109327T1 (es) |
| DE (1) | DE602004021605D1 (es) |
| DK (1) | DK1656365T3 (es) |
| EC (1) | ECSP066271A (es) |
| ES (1) | ES2327123T3 (es) |
| HK (1) | HK1086841A1 (es) |
| HR (1) | HRP20051019A2 (es) |
| IL (1) | IL172549A0 (es) |
| IS (1) | IS2674B (es) |
| LT (1) | LT5382B (es) |
| LV (1) | LV13441B (es) |
| MX (1) | MXPA06000325A (es) |
| NO (1) | NO20056175L (es) |
| NZ (1) | NZ544360A (es) |
| PE (1) | PE20050323A1 (es) |
| PL (1) | PL1656365T3 (es) |
| PT (1) | PT1656365E (es) |
| RS (1) | RS20050972A (es) |
| RU (1) | RU2352566C2 (es) |
| SG (1) | SG144914A1 (es) |
| SI (1) | SI1656365T1 (es) |
| TW (1) | TWI335915B (es) |
| UA (1) | UA83666C2 (es) |
| WO (1) | WO2005005410A1 (es) |
| ZA (1) | ZA200600019B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5080050B2 (ja) * | 2005-09-26 | 2012-11-21 | 住友化学株式会社 | 光学活性なピペラジン化合物の製造方法 |
| US20090275749A1 (en) * | 2005-09-26 | 2009-11-05 | Hiroshi Maeda | Production method of optically active piperazine compound |
| TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
| TW200815370A (en) * | 2006-06-16 | 2008-04-01 | Organon Nv | Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine |
| US8273883B2 (en) * | 2007-02-09 | 2012-09-25 | Kaneka Corporation | Method for producing optically active 2-arylpiperazine derivative |
| JP5192707B2 (ja) | 2007-03-22 | 2013-05-08 | 住友化学株式会社 | ミルタザピンの製造方法 |
| US7994314B2 (en) | 2007-04-11 | 2011-08-09 | N.V. Organon | Method for the preparation of an enantiomerically pure benzazepine |
| CA2684021A1 (en) | 2007-04-11 | 2008-10-23 | N.V. Organon | A method for the preparation of an enantiomer of a tetracyclic benzazepine |
| KR101485418B1 (ko) * | 2013-05-29 | 2015-01-26 | 주식회사 메디켐코리아 | 고순도 미르타자핀의 제조방법 |
| CA3013771C (en) | 2015-02-27 | 2024-01-02 | Kindred Biosciences, Inc. | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
| KR102540021B1 (ko) * | 2020-12-02 | 2023-06-07 | (주)유케이케미팜 | 대량 생산에 적합한 미르타자핀의 제조방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959470A (en) * | 1972-11-28 | 1976-05-25 | Mikhail Davidovich Mashkovsky | Psychotropic medicinal preparation |
| NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| TW206227B (es) * | 1989-10-05 | 1993-05-21 | Sankyo Co | |
| JPH11222407A (ja) * | 1997-11-14 | 1999-08-17 | Sankyo Co Ltd | 新規殺菌剤 |
| ATE289816T1 (de) | 1997-11-14 | 2005-03-15 | Akzo Nobel Nv | Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen |
| US20030069417A1 (en) * | 1999-04-19 | 2003-04-10 | Claude Singer | Novel synthesis and crystallization of piperazine ring-containing compounds |
| RU2001128229A (ru) * | 1999-04-19 | 2003-07-10 | Тева Фармасьютикал Индастриз Лтд. (Il) | Новый синтез и кристаллизация соединений, содержащих пиперазиновое кольцо |
| US6068695A (en) * | 1999-07-13 | 2000-05-30 | Bayer Corporation | Process for the continuous preparation of quinacridones |
| AU6476300A (en) | 1999-09-30 | 2001-05-10 | Sumika Fine Chemicals Co., Ltd. | Process for the preparation of a piperazine derivative |
| WO2001042239A1 (fr) * | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Procede de preparation d'un compose pyridinemethanol |
| CZ302368B6 (cs) | 2000-02-11 | 2011-04-13 | N.V. Organon | Farmaceutický prostredek |
| JP2001342188A (ja) * | 2000-03-27 | 2001-12-11 | Takeda Chem Ind Ltd | 縮合ピラゾール誘導体、その製造法および用途 |
| TW200538100A (en) * | 2004-04-21 | 2005-12-01 | Akzo Nobel Nv | Mirtazapine salts |
-
2004
- 2004-05-07 UA UAA200600274A patent/UA83666C2/ru unknown
- 2004-06-28 TW TW093118845A patent/TWI335915B/zh not_active IP Right Cessation
- 2004-07-05 AU AU2004255874A patent/AU2004255874B2/en not_active Expired
- 2004-07-05 CN CNB2004800194891A patent/CN100558722C/zh not_active Expired - Lifetime
- 2004-07-05 CA CA2531165A patent/CA2531165C/en not_active Expired - Fee Related
- 2004-07-05 SG SG200805127-8A patent/SG144914A1/en unknown
- 2004-07-05 US US10/564,193 patent/US8058436B2/en not_active Expired - Fee Related
- 2004-07-05 WO PCT/EP2004/051357 patent/WO2005005410A1/en active IP Right Grant
- 2004-07-05 DK DK04741958T patent/DK1656365T3/da active
- 2004-07-05 NZ NZ544360A patent/NZ544360A/en not_active IP Right Cessation
- 2004-07-05 RS YUP-2005/0972A patent/RS20050972A/sr unknown
- 2004-07-05 PT PT04741958T patent/PT1656365E/pt unknown
- 2004-07-05 ES ES04741958T patent/ES2327123T3/es not_active Expired - Lifetime
- 2004-07-05 JP JP2006518216A patent/JP4668184B2/ja not_active Expired - Lifetime
- 2004-07-05 BR BRPI0412447-2A patent/BRPI0412447A/pt not_active IP Right Cessation
- 2004-07-05 MX MXPA06000325A patent/MXPA06000325A/es active IP Right Grant
- 2004-07-05 DE DE602004021605T patent/DE602004021605D1/de not_active Expired - Lifetime
- 2004-07-05 AT AT04741958T patent/ATE433965T1/de active
- 2004-07-05 KR KR1020067000511A patent/KR20060056315A/ko active IP Right Grant
- 2004-07-05 RU RU2006103992/04A patent/RU2352566C2/ru not_active IP Right Cessation
- 2004-07-05 EP EP04741958A patent/EP1656365B1/en not_active Expired - Lifetime
- 2004-07-05 PL PL04741958T patent/PL1656365T3/pl unknown
- 2004-07-05 SI SI200431183T patent/SI1656365T1/sl unknown
- 2004-07-07 PE PE2004000653A patent/PE20050323A1/es not_active Application Discontinuation
- 2004-07-08 AR ARP040102412A patent/AR046494A1/es not_active Application Discontinuation
-
2005
- 2005-12-12 LT LT2005107A patent/LT5382B/lt not_active IP Right Cessation
- 2005-12-13 IL IL172549A patent/IL172549A0/en not_active IP Right Cessation
- 2005-12-15 IS IS8184A patent/IS2674B/is unknown
- 2005-12-22 HR HR20051019A patent/HRP20051019A2/xx not_active Application Discontinuation
- 2005-12-23 NO NO20056175A patent/NO20056175L/no not_active Application Discontinuation
-
2006
- 2006-01-03 ZA ZA200600019A patent/ZA200600019B/en unknown
- 2006-01-09 EC EC2006006271A patent/ECSP066271A/es unknown
- 2006-01-10 CO CO06001617A patent/CO5640123A2/es not_active Application Discontinuation
- 2006-02-10 LV LVP-06-21A patent/LV13441B/en unknown
- 2006-08-17 HK HK06109133.3A patent/HK1086841A1/xx not_active IP Right Cessation
-
2008
- 2008-07-02 US US12/667,969 patent/US20100179319A1/en not_active Abandoned
-
2009
- 2009-08-25 CY CY20091100894T patent/CY1109327T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV13441B (en) | A method for the preparation of enantiomercally pure mirtazapine | |
| US7482464B2 (en) | Processes for the preparation of S-(-)-amlodipine | |
| US20100160639A1 (en) | Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds | |
| JP2008545683A (ja) | （置換された）（ｒ）−又は（ｓ）−マンデル酸の動的分割のための方法 | |
| US20040176460A1 (en) | Process for the production of 3-phenylisoserine | |
| CN100448834C (zh) | 通过与手性碱环酰胺形成盐而拆分任选取代的扁桃酸的方法 | |
| JPH0748383A (ja) | 二環式ベータ−ラクタム／パラベン錯体 | |
| CN1356982A (zh) | 取代哌啶－4－酮类化合物的制备 | |
| EP2146993B1 (en) | A method for the preparation of mirtazapine | |
| US5578734A (en) | Method for the preparation of S-(+)-ethodolic acid and saline derivatives | |
| US20080255348A1 (en) | Method for the preparation of an enantiomer of a tetracyclic benzazepine | |
| AU724816B2 (en) | Process for the preparation of chiral, nonracemic(4-aryl-2,5-dioxoimidazolidin-1-yl)acetic acids | |
| WO1991001968A1 (en) | Phenyl-glycine derivatives | |
| WO2008026838A1 (en) | Method for preparing an optically active amlodipine | |
| EP1337533B1 (en) | Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine | |
| US20040110957A1 (en) | Process for the synthesis of an antiviral compound | |
| KR20000070367A (ko) | (1ｓ, 4ｒ)-1-아자비시클로[2,2,1]헵탄-3-온 및 (1ｒ, 4ｓ)-1-아자비시클로[2,2,1]헵탄-3-온의 제조 방법 |